Market Indices
Sector Heatmap
RPRX — Royalty Pharma plc Class A Ordinary Shares
NasdaqRoyalty Pharma plc Class A Ordinary Shares
- O
- 56.57
- H
- 56.71
- L
- 55.13
- V
- 2.54M
RPRX — Latest News & Headlines
18 StoriesWhy Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again Yahoo Finance
Royalty Pharma officer proposes $239K share sale | RPRX SEC Filing - Form 144 - Stock Titan
Royalty Pharma officer proposes $239K share sale | RPRX SEC Filing - Form 144 Stock Titan
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $235,594.60 in Stock - MarketBeat
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $235,594.60 in Stock MarketBeat
If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today - Benzinga
If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today Benzinga
(RPRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
(RPRX) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily
RPRX: Blockbuster Royalties Were The Hook, Synthetic Financing Drives The Upside - Simply Wall Street
RPRX: Blockbuster Royalties Were The Hook, Synthetic Financing Drives The Upside Simply Wall Street
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? - The Motley Fool
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? The Motley Fool
4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. - Stock Titan
4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. Stock Titan
Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $67 - Moomoo
Morgan Stanley Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $67 Moomoo
RPRX Apr 2027 85.000 call (RPRX270416C00085000) Stock Price, News, Quote & History - Yahoo! Finance Canada
RPRX Apr 2027 85.000 call (RPRX270416C00085000) Stock Price, News, Quote & History Yahoo! Finance Canada
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock - MarketBeat
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock MarketBeat
Royalty Pharma (RPRX) Slips 0.82% to $57.16 as Shares Test Mid-Range Support - Large Cap Trends - https://www.dars.gov.et/
Royalty Pharma (RPRX) Slips 0.82% to $57.16 as Shares Test Mid-Range Support - Large Cap Trends https://www.dars.gov.et/
Officer Marshall Urist proposes selling 4,126 Royalty Pharma (RPRX) shares. - Stock Titan
Officer Marshall Urist proposes selling 4,126 Royalty Pharma (RPRX) shares. Stock Titan
RPRX Apr 2027 50.000 call (RPRX270416C00050000) Stock Price, News, Quote & History - Yahoo! Finance Canada
RPRX Apr 2027 50.000 call (RPRX270416C00050000) Stock Price, News, Quote & History Yahoo! Finance Canada
527,094 Shares of Royalty Pharma PLC $RPRX Bought by Congress Asset Management Co. - MarketBeat
527,094 Shares of Royalty Pharma PLC $RPRX Bought by Congress Asset Management Co. MarketBeat
At $57.10 a share, Royalty Pharma (RPRX) EVP Marshall Urist sells 4,126 shares. - Stock Titan
At $57.10 a share, Royalty Pharma (RPRX) EVP Marshall Urist sells 4,126 shares. Stock Titan
Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen MarketBeat
RPRX 8-K & SEC Filings - Yahoo! Finance Canada
RPRX 8-K & SEC Filings Yahoo! Finance Canada